BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35576922)

  • 1. First application of the BIANCA biophysical model to carbon-ion patient cases.
    Kozłowska WS; Carante MP; Aricò G; Embriaco A; Ferrari A; Magro G; Mairani A; Ramos R; Sala P; Georg D; Ballarini F
    Phys Med Biol; 2022 May; 67(11):. PubMed ID: 35576922
    [No Abstract]   [Full Text] [Related]  

  • 2. In Vivo Validation of the BIANCA Biophysical Model: Benchmarking against Rat Spinal Cord RBE Data.
    Carante MP; Aricò G; Ferrari A; Karger CP; Kozlowska W; Mairani A; Sala P; Ballarini F
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32492909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthy Tissue Damage Following Cancer Ion Therapy: A Radiobiological Database Predicting Lymphocyte Chromosome Aberrations Based on the BIANCA Biophysical Model.
    Embriaco A; Ramos R; Carante M; Ferrari A; Sala P; Vercesi V; Ballarini F
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiobiological damage by space radiation: extension of the BIANCA model to heavy ions up to iron, and pilot application to cosmic ray exposure.
    Ramos RL; Embriaco A; Carante MP; Ferrari A; Sala P; Vercesi V; Ballarini F
    J Radiol Prot; 2022 May; 42(2):. PubMed ID: 35453133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First benchmarking of the BIANCA model for cell survival prediction in a clinical hadron therapy scenario.
    Carante MP; Aricò G; Ferrari A; Kozlowska W; Mairani A; Ballarini F
    Phys Med Biol; 2019 Oct; 64(21):215008. PubMed ID: 31569085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of potential advantages of relevant ions for particle therapy: a model based study.
    Grün R; Friedrich T; Krämer M; Zink K; Durante M; Engenhart-Cabillic R; Scholz M
    Med Phys; 2015 Feb; 42(2):1037-47. PubMed ID: 25652516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal lobe reactions after carbon ion radiation therapy: comparison of relative biological effectiveness-weighted tolerance doses predicted by local effect models I and IV.
    Gillmann C; Jäkel O; Schlampp I; Karger CP
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1136-41. PubMed ID: 24661667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical note: Impact of beamline-specific particle energy spectra on clinical plans in carbon ion beam therapy.
    Resch AF; Schafasand M; Lackner N; Niessen T; Beck S; Elia A; Boersma D; Grevillot L; Fossati P; Glimelius L; Stock M; Georg D; Carlino A
    Med Phys; 2022 Jun; 49(6):4092-4098. PubMed ID: 35416302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling secondary cancer risk ratios for proton versus carbon ion beam therapy: A comparative study based on the local effect model.
    Hufnagl A; Johansson G; Siegbahn A; Durante M; Friedrich T; Scholz M
    Med Phys; 2022 Aug; 49(8):5589-5603. PubMed ID: 35717591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological effectiveness of He-3 and He-4 ion beams for cancer hadrontherapy: a study based on the BIANCA biophysical model.
    Carante MP; Embriaco A; Aricò G; Ferrari A; Mairani A; Mein S; Ramos R; Sala P; Ballarini F
    Phys Med Biol; 2021 Sep; 66(19):. PubMed ID: 34507306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RBE-weighted doses in target volumes of chordoma and chondrosarcoma patients treated with carbon ion radiotherapy: Comparison of local effect models I and IV.
    Gillmann C; Jäkel O; Karger CP
    Radiother Oncol; 2019 Dec; 141():234-238. PubMed ID: 31522880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model.
    Wang W; Li P; Sheng Y; Huang Z; Zhao J; Hong Z; Shahnazi K; Jiang GL; Zhang Q
    Radiat Oncol; 2021 Apr; 16(1):72. PubMed ID: 33849589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organs at risk dose constraints in carbon ion radiotherapy at MedAustron: Translations between LEM and MKM RBE models and preliminary clinical results.
    Grosshagauer S; Fossati P; Schafasand M; Carlino A; Poljanc K; Radakovits T; Stock M; Hug E; Georg P; Pelak M; Góra J
    Radiother Oncol; 2022 Oct; 175():73-78. PubMed ID: 35952977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a prospective randomized trial on long-term effectiveness of protons and carbon ions in prostate cancer: LEM I and α/β = 2 Gy overestimates the RBE.
    Eichkorn T; Karger CP; Brons S; Koerber SA; Mielke T; Haberer T; Debus J; Herfarth K
    Radiother Oncol; 2022 Aug; 173():223-230. PubMed ID: 35714806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fast Biological Modeling for Voxel-based Heavy Ion Treatment Planning Using the Mechanistic Repair-Misrepair-Fixation Model and Nuclear Fragment Spectra.
    Kamp F; Cabal G; Mairani A; Parodi K; Wilkens JJ; Carlson DJ
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):557-68. PubMed ID: 26460998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Monte Carlo-based treatment-planning tool for ion beam therapy.
    Böhlen TT; Bauer J; Dosanjh M; Ferrari A; Haberer T; Parodi K; Patera V; Mairani A
    J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i77-81. PubMed ID: 23824131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity study of the microdosimetric kinetic model parameters for carbon ion radiotherapy.
    Dahle TJ; Magro G; Ytre-Hauge KS; Stokkevåg CH; Choi K; Mairani A
    Phys Med Biol; 2018 Nov; 63(22):225016. PubMed ID: 30418940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spot-scanning hadron arc (SHArc) therapy: A proof of concept using single- and multi-ion strategies with helium, carbon, oxygen, and neon ions.
    Mein S; Kopp B; Tessonnier T; Liermann J; Abdollahi A; Debus J; Haberer T; Mairani A
    Med Phys; 2022 Sep; 49(9):6082-6097. PubMed ID: 35717613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of mechanism-inspired models for particle relative biological effectiveness (RBE).
    Stewart RD; Carlson DJ; Butkus MP; Hawkins R; Friedrich T; Scholz M
    Med Phys; 2018 Nov; 45(11):e925-e952. PubMed ID: 30421808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of enhancements in the local effect model (LEM) on the predicted RBE-weighted target dose distribution in carbon ion therapy.
    Grün R; Friedrich T; Elsässer T; Krämer M; Zink K; Karger CP; Durante M; Engenhart-Cabillic R; Scholz M
    Phys Med Biol; 2012 Nov; 57(22):7261-74. PubMed ID: 23075883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.